Temasek raised W895 billion ($793 million) from another partial sale in South Korean biopharmaceutical firm Celltrion on Monday, moving quickly to sell the shares shortly after the lockup period for its previous sale expired last month.
¬ Haymarket Media Limited. All rights reserved.
